Sonata Capital Group’s iShares Biotechnology ETF IBB Stock Holding History

Sonata Capital Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,430	Closed	-$218K	–	121
2021 Q4	$218K	Sell	1,430 -100	-7%	-$15.5K	0.09%	117
2021 Q3	$247K	Buy	+1,530	New	+$257K	0.11%	115
2016 Q1	–	Sell	-2,280	Closed	-$257K	–	99
2015 Q4	$257K	Buy	+2,280	New	+$247K	0.23%	86
2015 Q3	–	Sell	-1,680	Closed	-$207K	–	96
2015 Q2	$207K	Buy	+1,680	New	+$201K	0.18%	95

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sonata Capital Group's IBB Position: Q1 2022 in Review

Sonata Capital Group sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,430 shares — an estimated $218K sold.

Sonata Capital Group first reported a position in IBB in Q2 2015 and held it in 4 quarters. The position peaked at $257K in Q4 2015. 898 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Sonata Capital Group reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Sonata Capital Group sold 1,430 iShares Biotechnology ETF shares in Q1 2022, an estimated $218K.
Sonata Capital Group first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 4 quarters.
Sonata Capital Group's iShares Biotechnology ETF position peaked at $257K in Q4 2015.
898 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Sonata Capital Group's 13F filing for Q1 2022, filed 22 Apr 2022.